Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer

NCT05117242 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer Metastatic

Interventions

BIOLOGICAL: Acasunlimab
BIOLOGICAL: Pembrolizumab

Sponsor

Genmab

Collaborators

[object Object]